Clinical Trial

Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes

Recruiting
View on ClinicalTrials.gov →
Summary
D5W) has long been used as an intravenous fluid for hydration and energy supplementation and has recently gained increasing clinical interest in perineural injection therapies and ultrasound-guided hydrodissection. D5W has been shown to improve pain and functional outcomes in entrapment neuropathies by mechanically releasing perineural adhesions and potentially modulating neurogenic inflammation. In contrast, 0.9% sodium chloride (normal saline) is routinely used as a dilution medium for local anesthetics in peripheral nerve blocks; however, emerging evidence suggests that alternative diluents such as D5W may influence block onset and efficacy. The infraclavicular block is a commonly used ultrasound-guided technique for brachial plexus anesthesia, providing reliable anesthesia and postoperative analgesia for upper extremity surgery. This study aims to compare the effects of diluting bupivacaine with either D5W or 0.9% NaCl on block success and duration of analgesia in patients undergoing infraclavicular block. Secondary outcomes include block onset characteristics, sensory and motor block profiles, and perioperative analgesic requirements. The findings may help determine whether D5W represents a safe and effective alternative diluent to saline in routine regional anesthesia practice.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-05-15 -> 2026-06-15 2026-06-24
Trial Details
NCT Number NCT07386327
Lead Sponsor Burçin Alaçam, MD
Conditions Infraclavicular Brachial Plexus Block, Dextrose, Bupivacaine, Block Success, Postoperative Analgesia
Enrollment 90 participants
Start Date 2026-03-09
Primary Completion 2026-06-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-23